Abstract P026 – Table 1. HIV‐1 RNA <50 copies/mL at week 52 (Snapshot algorithm) by subgroup.
Subgroups	Randomized cohort (n = 36)
Overall	83% (30/36)
Baseline CD4 (cells/μL) <200	78% (21/27)
Baseline CD4 (cells/μL) ≥200	100% (9/9)
Baseline HIV‐1 RNA (copies/mL) ≤100 000	86% (25/29)
Baseline HIV‐1 RNA (copies/mL) >100 000	71% (5/7)
With INSTI resistance	81% (22/27)
Without INSTI resistance	88% (7/8)
0 fully active agents in OBR	67% (4/6)
1 fully active agent in OBR	79% (11/14)
≥2 fully active agents in OBR	94% (15/16)
With dolutegravir	83% (15/18)
Without dolutegravir	83% (15/18)
With darunavir	86% (18/21)
Without darunavir	80% (12/15)
With ibalizumab	83% (10/12)
Without ibalizumab	83% (20/24)